Carteolol
Carteolol
Definition
A synthetic quinolinone derivative and nonselective beta-adrenoceptor blocking agent with anti-glaucoma activity. Upon topical administration to the eye, carteolol decreases aqueous humor production, thereby reducing intraocular pressure (IOP).
Also known as CARTEOLOL — per NCIT
Also identified as
- ATC C07AA15 per RXNORM
- ATC S01ED05 per RXNORM
- NCIT NCIT:C65291 per NCIT
- SCTID 108544005 per RXNORM
- SCTID 386866004 per RXNORM
- UNII 8NF31401XG per RXNORM
Indications
| Disease | Relation | Source |
|---|---|---|
| Hypertensive disorder | may treat | MEDRT · Public domain (U.S. Government work) |
| Open-angle glaucoma | may treat | MEDRT · Public domain (U.S. Government work) |
Organ Effects
| Organ | Side effect / interaction | Source |
|---|---|---|
| Camera-type eye | may treat a disease of this organ | DERIVED · CC BY 4.0 |
1 entry above is marked DERIVED: Atlas Médico inferred it by combining two sourced claims, and no source asserts this link directly. Treat it as a navigation aid, not as a clinical statement.